Pharmacy Practice & Development

Policy on the Use of Standard Formulation of Extemporaneous / Galenical / Sterile Preparation and Practice and Procedure on Drug Formulation Request for Extemporaneous/ Galenical/ Sterile Preparation

The Policy on the Use of Standard Formulation of Extemporaneous / Galenical / Sterile Preparation and Practice and Procedure on Drug Formulation Request for Extemporaneous/ Galenical/ Sterile Preparation are established to ensure that each application submitted by pharmacist in MOH facilities follows a systematic procedure.

English

Guideline on Ward Pharmacy Activities, First Edition 2023

The Guideline on Ward Pharmacy Activities First Edition 2023, is the latest guidelines published under the Pharma

English

Garis Panduan Pharmacy Integrated Community Care (PICC)

Pharmacy Integrated Community Care (PICC) is an initiative to optimize the treatment of diabetic patients in the community. PICC includes sharing sessions on medication management, healthy lifestyle practices, and promoting a balanced diet.

English

Position Statements on the Use of Biosimilars in the Ministry of Health, Malaysia Healthcare Facilities

The increasing use of biological medicines including biosimilars in the Ministry of Health (MOH), Malaysia facilities warrants a suitable guidance document to ensure safe

English

Garis Panduan Peminjaman Ubat-ubatan oleh Hospital/Klinik Perubatan Swasta dari Hospital di bawah KKM Semasa Krisis Bekalan Ubat-ubatan di Pasaran Malaysia

Garis panduan ini bertujuan untuk menguatkuasakan pemakaian Panduan Peminjaman Ubat-ubatan oleh hospital/Klinik Perubatan Swasta dari Hospital di bawah Kementerian Kesihatan Malaysia (KKM) semasa Krisis Bekalan Ubat-ubatan di Pasaran Malaysia.

Panduan ini adalah untuk rujukan mana-mana Pengamal Perubatan Swasta dari sesebuah hospital atau klinik perubatan swasta yang berdaftar di bawah Akta Kemudahan dan Perkhidmatan Jagaan Kesihatan Swasta 1998 [Akta 586] yang ingin membuat peminjaman bekalan ubat-ubatan berkaitan isu krisis bekalan ubat di pasaran Malaysia.

English

COST-BENEFIT ANALYSIS OF THE MEDICINES PRICE MECHANISM

Regulatory Impact Analysis (RIA) is a systematic process of identifying and assessing the likely impact of the proposed regulation using a consistent analytical method, such as cost-benefit analysis (CBA). RIA is a requirement by Malaysia Productivity Corporation (MPC) for any agencies intended to implement changes in the regulation.

English

ANTIDOTE QUICK GUIDE (ADULT DOSE)

This guideline is prepared to facilitate the healthcare personnel to react fast. It is hoped to provide guidance to emergency personnel on proper storage, selection, availability, and proper use to reducing poisoning and overdose injuries or deaths by assisting in the early recognition of toxic exposures and guiding emergency personnel on the proper storage, selection, availability, and proper use of antidotal therapies. This guideline will assist in the promotion of quality clinical care pharmacy services throughout Ministry of Health facilities.

English

Medicine Prices Monitoring Survey in Malaysia 2020

Medicine Prices Monitoring Survey in Malaysia / Kajian Pemantauan Harga Ubat (KPHU) is a commitment of the Pharmaceutical Services Program (PSP) to provide comprehensive information on the availability, price and affordability of medicines in Malaysia. The study conducted since 2006 requires cooperation between Malaysia's public and private healthcare sectors. The selection of facilities and medicines was based on the World Health Organization (WHO) and Health Action International (HAI) guidelines.

English

Polisi Operasi Farmasi Ambulatori 2022 (Edisi Kedua)

This document explains the policy related to ambulatory pharmacy operation services in health facilities of the Ministry of Health Malaysia (MOH). This policy has been updated in line with current developments to ensure services are standardized in MOH health facilities.

English

Pages